CXBS — Corix Bioscience Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$0.31m
- $0.69m
Annual balance sheet for Corix Bioscience, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2012 January 31st | C2013 January 31st | 2014 January 31st | 2015 January 31st | C2016 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-Q | 10-K | 10-K | 10-Q |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0 | 0 | 0 | 0 | 0.002 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0 | 0 | 0.001 | 0 | 0.238 |
Net Property, Plant And Equipment | — | — | — | — | 0.005 |
Other Long Term Assets | |||||
Total Assets | 0 | 0 | 0.001 | 0 | 11.4 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.013 | 0.017 | 0.024 | 0 | 1.07 |
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.013 | 0.017 | 0.024 | 0 | 6.89 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -0.013 | -0.017 | -0.023 | 0 | 4.48 |
Total Liabilities & Shareholders' Equity | 0 | 0 | 0.001 | 0 | 11.4 |
Total Common Shares Outstanding |